Dedifferentiated endometrial carcinoma metastasis to axillary lymph node: a case report

被引：2

作者：

Morrison, Chase William ^{[1
]}

Sanjasaz, Kayvon Nick ^{[1
]}

Nathanson, Saul David ^{[2
,3
]}

Raina-Hukku, Supriya ^{[4
]}

Pinkney, David Matthew ^{[5
]}

Davenport, Alexis Anna ^{[5
]}

机构：

[1] Wayne State Univ, Detroit, MI USA

[2] Henry Ford Hlth, Dept Surg, 2799 W Grand Blvd, Detroit, MI 48202 USA

[3] Wayne State Univ Med Sch, 2799 W Grand Blvd, Detroit, MI 48202 USA

[4] Henry Ford Hlth, Dept Otolaryngol, Detroit, MI USA

[5] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI USA

来源：

JOURNAL OF MEDICAL CASE REPORTS | 2023年 / 17卷 / 01期

关键词：

Case report; Endometrial carcinoma; Immunotherapy; Metastatic carcinoma; Axillary mass; BLOOD-VESSELS; CANCER; TUMOR; EXIT;

D O I：

10.1186/s13256-023-04192-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background We present an unusual case of a left axillary lymph node metastasis from a primary dedifferentiated endometrial carcinoma. This pattern of metastasis is likely the result of circulating tumor cells reaching the node through its arterial blood supply. Case presentation In this report, a 68-year-old white woman with a dedifferentiated endometrial carcinoma underwent a hysterectomy. She later developed an enlarged axillary lymph node due to metastatic dedifferentiated endometrial carcinoma, treated with chemotherapy and anti-programmed cell death protein 1 immunotherapy resulting in a complete clinical and radiological response. Conclusion A review of the literature reveals the rarity of blood-borne lymph node metastasis, especially with uterine carcinoma. Immunotherapy has shown promising results in the treatment of some subtypes of metastatic uterine carcinoma.

引用

页数：7

共 33 条

[1]

Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO

[2]

2-Y

[3] Pembrolizumab in endometrial cancer: Where we stand now [J].